Overactive Bladder

29 competing products in clinical development for Overactive Bladder.

Pipeline by Phase

Pre-clinical7

Phase 13

Phase 25

Phase 34

Approved10

All Products (29)

Product	Company	Stage	Status	Hype
mirabegron + solifenacin	Astellas Pharma	Approved	Completed	43
Solifenacin	Astellas Pharma	Approved	Completed	43
Solifenacin succinate	Astellas Pharma	Approved	Completed	43
Solifenacin Succinate Tablets + Estrogen	Astellas Pharma	Approved	Completed	43
Solifenacin Succinate + Placebo	Astellas Pharma	Approved	Completed	43
Mirabegron	Astellas Pharma	Approved	Completed	43
Mirabegron + Placebo + Tamsulosin	Astellas Pharma	Approved	Completed	43
Solifenacin	Astellas Pharma	Approved	Completed	43
solifenacin + oxybutynin immediate release	Astellas Pharma	Approved	Completed	43
solifenacin	Astellas Pharma	Approved	Completed	43
Solifenacin succinate	Astellas Pharma	Phase 3	Completed	40
imidafenacin, KRP-197/ONO-8025 + imidafenacin, KRP-197/ONO-8025	Ono Pharmaceutical	Phase 3	Completed	40
ONO-8025 (KRP-197)	Ono Pharmaceutical	Phase 3	Completed	40
Solifenacin	Astellas Pharma	Phase 2	Completed	35
YM178	Astellas Pharma	Phase 2	Completed	35
Placebo + Tolterodine + ONO-8539 + ONO-8539 + ONO-8539	Ono Pharmaceutical	Phase 2	Completed	35
ONO-8025 (KRP-197)	Ono Pharmaceutical	Phase 2	Completed	35
ONO-8577 + solifenacin succinate + mirabegron + Placebo	Ono Pharmaceutical	Phase 2	Completed	35
Vesicare (solifenacin)	Astellas Pharma	Phase 3	Terminated	32
warfarin + YM178	Astellas Pharma	Phase 1	Completed	29
Solifenacin succinate suspension 5 mg	Astellas Pharma	Phase 1	Completed	29
mirabegron	Astellas Pharma	Phase 1	Completed	29
Betanis	Astellas Pharma	Pre-clinical	Completed	26
Solifenacin	Astellas Pharma	Pre-clinical	Completed	26
Mirabegron	Astellas Pharma	Pre-clinical	Completed	26
Betanis	Astellas Pharma	Pre-clinical	Completed	26
Vesicare	Astellas Pharma	Pre-clinical	Completed	26
mirabegron	Astellas Pharma	Pre-clinical	Completed	26
Solifenacin	Astellas Pharma	Pre-clinical	Terminated	18